Novoray Balance Sheet Health

Financial Health criteria checks 5/6

Novoray has a total shareholder equity of CN¥1.4B and total debt of CN¥118.6M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥1.8B and CN¥453.5M respectively. Novoray's EBIT is CN¥216.1M making its interest coverage ratio -15.9. It has cash and short-term investments of CN¥554.2M.

Key information

8.6%

Debt to equity ratio

CN¥118.64m

Debt

Interest coverage ratio-15.9x
CashCN¥554.20m
EquityCN¥1.37b
Total liabilitiesCN¥453.50m
Total assetsCN¥1.83b

Recent financial health updates

Recent updates

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26
What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Jul 29
Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Jul 13
What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Jun 19
Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27
When Should You Buy Novoray Corporation (SHSE:688300)?

Financial Position Analysis

Short Term Liabilities: 688300's short term assets (CN¥989.1M) exceed its short term liabilities (CN¥301.8M).

Long Term Liabilities: 688300's short term assets (CN¥989.1M) exceed its long term liabilities (CN¥151.8M).


Debt to Equity History and Analysis

Debt Level: 688300 has more cash than its total debt.

Reducing Debt: 688300's debt to equity ratio has increased from 8.2% to 8.6% over the past 5 years.

Debt Coverage: 688300's debt is well covered by operating cash flow (199%).

Interest Coverage: 688300 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies